Clinical Report: Endophthalmitis: A Case for Acting Early
Overview
A Phase 2 feasibility study suggests that early surgical intervention, specifically pars plana vitrectomy within 48–96 hours of diagnosis, may significantly improve visual outcomes in patients with endophthalmitis compared to conventional antibiotic-first treatment.
Background
Acute endophthalmitis is a rare but serious condition that can lead to severe visual impairment or blindness following intraocular procedures. The challenge for clinicians lies in the timely eradication of infection to preserve vision. Recent advancements in vitreoretinal surgery have prompted a reevaluation of early surgical intervention strategies in managing this condition.
Data Highlights
| Group | Median Improvement (Letters) | Range (Letters) |
|---|---|---|
| Early Vitrectomy | 40 | 28–70 |
| Conventional Antibiotic-first | 13 | 0–66 |
Key Findings
- Early vitrectomy within 48–96 hours resulted in a median improvement of 40 letters in visual acuity.
- The conventional antibiotic-first approach yielded a median gain of only 13 letters.
- Recovery occurred sooner in the early vitrectomy group compared to those receiving antibiotics first.
- Non-serious adverse events were reported in 47% of the early vitrectomy group versus 68% in the antibiotic-first group.
- The study highlights the feasibility of early surgical intervention across multiple centers.
- Advancements in surgical techniques may enhance the risk-benefit profile of early vitrectomy.
Clinical Implications
Clinicians should consider the potential benefits of early vitrectomy in managing this condition.
Conclusion
Further research in larger trials is necessary to confirm these findings.
Related Resources & Content
- Retinal Physician, Endophthalmitis Then and Now, 2025 -- Endophthalmitis Then and Now
- Ophthalmology Management, How to Prevent and Manage Postoperative Endophthalmitis Recommendations, 2012 -- How to Prevent and Manage Postoperative Endophthalmitis
- Retinal Physician, Endophthalmitis Rates Drop 75% since 2000, 2024 -- Endophthalmitis Rates Drop 75% since 2000
- Retinal Physician, Endophthalmitis in the Modern Era, 2016 -- Endophthalmitis in the Modern Era
- Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States - PMC -- Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States
- Do Treatment Patterns for Endophthalmitis after Cataract Surgery Follow the Endophthalmitis Vitrectomy Study Recommendations?: An Academy IRIS® Registry Analysis - ScienceDirect -- Do Treatment Patterns for Endophthalmitis after Cataract Surgery Follow the Endophthalmitis Vitrectomy Study Recommendations?
- State-of-the-Art Review: Ocular Infections - PMC -- State-of-the-Art Review: Ocular Infections
- Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States - PMC
- Do Treatment Patterns for Endophthalmitis after Cataract Surgery Follow the Endophthalmitis Vitrectomy Study Recommendations?: An Academy IRIS® Registry Analysis - ScienceDirect
- State-of-the-Art Review: Ocular Infections - PMC
Based on findings from:
Endophthalmitis: A Case for Acting Early
The Ophthalmologist, 2026.
https://theophthalmologist.com/issues/2026/articles/september/endophthalmitis-a-case-for-acting-early/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
